189 related articles for article (PubMed ID: 8932338)
1. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
Munn KE; Walker RA; Menasce L; Varley JM
Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
[TBL] [Abstract][Full Text] [Related]
2. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
[TBL] [Abstract][Full Text] [Related]
3. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
4. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.
Munn KE; Walker RA; Menasce L; Varley JM
Br J Cancer; 1996 Mar; 73(5):636-9. PubMed ID: 8605099
[TBL] [Abstract][Full Text] [Related]
5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
6. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
7. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
[TBL] [Abstract][Full Text] [Related]
8. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
Chen T; Dhingra K; Sahin A; Sneige N; Hortobagyi G; Aldaz CM
Breast Cancer Res Treat; 1996; 39(2):177-85. PubMed ID: 8872326
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
11. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
Done SJ; Eskandarian S; Bull S; Redston M; Andrulis IL
J Natl Cancer Inst; 2001 May; 93(9):700-4. PubMed ID: 11333292
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
13. In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology.
Ho GH; Calvano JE; Bisogna M; Borgen PI; Rosen PP; Tan LK; Van Zee KJ
Cancer; 2000 Dec; 89(11):2153-60. PubMed ID: 11147584
[TBL] [Abstract][Full Text] [Related]
14. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
Rane SU; Mirza H; Grigoriadis A; Pinder SE
Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
Visscher DW; Wallis TL; Crissman JD
Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ.
Visscher D; Jimenez RE; Grayson M; Mendelin J; Wallis T
Hum Pathol; 2000 Feb; 31(2):201-7. PubMed ID: 10685634
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
Ando Y; Iwase H; Ichihara S; Toyoshima S; Nakamura T; Yamashita H; Toyama T; Omoto Y; Karamatsu S; Mitsuyama S; Fujii Y; Kobayashi S
Cancer Lett; 2000 Aug; 156(2):207-14. PubMed ID: 10880771
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
